டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் Today - Breaking & Trending Today

Factbox: Latest on the worldwide spread of the coronavirus


By Syndicated Content
Apr 29, 2021 | 12:45 PM
(Reuters) – India’s total COVID-19 cases passed 18 million on Thursday after another world record number of daily infections, as gravediggers worked around the clock to bury victims and hundreds more were cremated in makeshift pyres in parks and parking lots.
DEATHS AND INFECTIONS Eikon users, see COVID-19: MacroVitals https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1592404098 for a case tracker and summary of news
EUROPE
EU contracts for COVID-19 vaccines to be delivered in 2022/23 contain clear rules about what would happen if the vaccine makers do not deliver, Germany’s Health Minister said.
Germany has managed to break the rapid rise in new infections, but it is still too early to sound the all-clear, the head of the Robert Koch Institute said. ....

Hong Kong , New York , United States , Sarah Morland , Sonya Hepinstall , Katherine Tai , Joe Biden , Germany Health , Developers Of Russia Sputnik , Robert Koch Institute , Federal Reserve , Health Minister , New York City , Mayor Bill De Blasio , Democratic Republic , Representative Katherine Tai , Three Lonza , ஹாங் காங் , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சாரா மார்‌ல்யாஂட் , க்யாதரிந் தை , ஓஹோ பிடென் , ஜெர்மனி ஆரோக்கியம் , டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் , ராபர்ட் கோச் நிறுவனம் ,

Brazil's regulator not allowing Sputnik V's import due to political reasons - developers - Russia


Brazil’s regulator not allowing Sputnik V’s import due to political reasons - developers
The delay by Anvisa to issue permission for the import and use of the Sputnik V vaccine has nothing to do with access to data on the vaccine or science, the vaccine’s Twitter account said
MOSCOW, April 27. /TASS/. Developers of Russia’s Sputnik V COVID-19 vaccine believe that the refusal of the Brazilian Health Regulatory Agency (Anvisa) to allow its import is politically motivated, the vaccine’s Twitter account said.
The delay by the Brazilian Health Regulatory Agency (Anvisa) to issue permission for the import and use of the Sputnik V vaccine in the country is unfortunately of political nature and has nothing to do with access to data on the vaccine or science, the developers said on their official Twitter account. ....

United States , Uniao Quimica , Fernando Marques , Developers Of Russia Sputnik , Brazilian Health Regulatory Agency Anvisa , Russian Direct Investment Fund , Brazilian Health Regulatory Agency , ஒன்றுபட்டது மாநிலங்களில் , ஊனியஓ குவிமிகா , பெர்னாண்டோ மார்க்ஸ் , டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் , ரஷ்ய நேரடி முதலீடு நிதி ,

Sputnik V developers demand apology from European Medicines Agency official


Sputnik V developers demand apology from European Medicines Agency official
Such comments are inappropriate and undermine credibility of EMA and its review process, the Sputnik V team said
© Kirill Kukhmar/TASS
MOSCOW, March 9. /TASS/. Developers of Russia’s Sputnik V vaccine against the novel coronavirus have demanded an apology from Chair of the European Medicines Agency (EMA) Management Board Christa Wirthumer-Hoche for comparing the possibility of approving the emergency use of the vaccine with a ‘Russian roulette.’
We demand a public apology from EMA’s Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V. Her comments raise serious questions about possible political interference in the ongoing EMA review. Sputnik V is approved by 46 nations, reads a post on the vaccine’s official Twitter account. ....

Kirill Dmitriev , Christa Wirthumer Hoche , Developers Of Russia Sputnik , European Medicines Agency , Head Of The Russian Direct Investment Fund , Devices Agency , Management Board Christa Wirthumer Hoche , Austrian Medicines , Medical Devices Agency , Russian Direct Investment Fund , டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் , தலை ஆஃப் தி ரஷ்ய நேரடி முதலீடு நிதி , ஆஸ்திரேலிய மருந்துகள் , ரஷ்ய நேரடி முதலீடு நிதி ,

Sputnik V developers demand apology from European Medicines Agency


9 Mar in 12:00
Developers of Russia’s Sputnik V vaccine against the novel coronavirus have demanded an apology from Chair of the European Medicines Agency (EMA) Management Board Christa Wirthumer-Hoche for comparing the possibility of approving the emergency use of the vaccine with a ‘Russian roulette.’
We demand a public apology from EMA’s Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V. Her comments raise serious questions about possible political interference in the ongoing EMA review. Sputnik V is approved by 46 nations, reads a post on the vaccine’s official Twitter account.
EMA did not allow such statements about any other vaccine. Such comments are inappropriate and undermine credibility of EMA and its review process. Vaccines and EMA should be above and beyond politics, it says. ....

Christa Wirthumer Hoche , Developers Of Russia Sputnik , European Medicines Agency , Devices Agency , Management Board Christa Wirthumer Hoche , Austrian Medicines , Medical Devices Agency , டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் , ஆஸ்திரேலிய மருந்துகள் ,

Sputnik V developers to continue cooperation with EU and AstraZeneca


Only a diversified portfolio of vaccines can reduce technology and supply risks, the developers stressed
MOSCOW, January 24. /TASS/. Developers of Russia’s Sputnik V anti-coronavirus vaccine said on Sunday they will continue to work with the European Union and AstraZeneca, a British-Sweden pharmaceutical company, to ensure access to the Russian vaccine and its components across the globe.
Only a diversified portfolio of vaccines can reduce technology and supply risks. SputnikV, already approved by 12 nations, will continue its work with EU and AstraZeneca to enable access to the Sputnik V vaccine and its components worldwide, as follows from a message posted on the Sputnik V official Twitter account. ....

United Kingdom , Developers Of Russia Sputnik , European Union , European Commission , Gamaleya Center The Sputnik , Russian Direct Investment Fund , Gamaleya Center , ஒன்றுபட்டது கிஂக்டம் , டெவலப்பர்கள் ஆஃப் ரஷ்யா ஸ்பட்நிக் , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய தரகு , ரஷ்ய நேரடி முதலீடு நிதி ,